
Biopharmaceutical Analysis
Latest News
Latest Videos

More News

Johnson & Johnson's modeling projects 18.5-year life expectancy with Tecvayli-Darzalex versus 4.9 years for standard care.

FDA's new rule formally recognizes non-animal methods like organoids and AI models as valid ways to support human drug testing.

New data show risk-based and centralized monitoring shifts effort across roles, sites, and timelines, reshaping how sponsors plan CRA capacity needs.

Webcasts
Webinar Date/Time: Thu, Oct 8, 2026 10:00 AM EDT

Here's what you need to know about how stability programs assess potency and purity in complex biologics, like bispecific antibodies, under ICH Q5C and FDA guidance.

Nucleai has announced an ongoing translational research collaboration with Gilead Sciences applying AI-powered tissue analytics to support Gilead's global antibody-drug conjugate clinical development programs, generating candidate spatial biomarkers across multiple oncology indications.

Dash Bio has raised $30 million in Series A financing led by Oak HC/FT to scale its automated, GLP-compliant bioanalysis platform, bringing total funding to $47.5 million as the company works to compress preclinical and clinical sample-testing timelines.

Precision analytics and flexible manufacturing are helping to advance safer, scalable bispecific antibodies, antibody-drug conjugates, and central nervous system monoclonal antibodies from development to patients.

Planning the analytical strategy for product release should be started as early as possible to ensure product quality and regulatory success.

We answer readers’ top questions on limit of blank, limit of detection, limit of quantitation, acceptance criteria, and equivalence testing in analytical method validation.

CMC teams can align with Q5A(R2)’s updated guidance to shorten testing timelines and strengthen assurance of participant safety.

GSK will invest £400 million (US$532 million) in a new Cambridge, UK, R&D center, relocating from Stevenage amid second quarter earnings and a cost-savings plan.

Webcasts
Webinar Date/Time: Fri, Aug 21, 2026 11:00 AM EDT

Liquid chromatography and single-use chromatography platforms are reshaping biologics purification as the Asia-Pacific region challenges the dominance of North America and Europe.

Webcasts
Webinar Date/Time: Thu, Aug 6, 2026 11:00 AM EDT

Webcasts
Webinar Date/Time: Tue, Jun 30, 2026 11:00 AM EDT

AI adoption is no longer an abstract innovation exercise, but has become a critical lever for survival across the pharmaceutical landscape, characterized by compressed competitive windows and soaring development costs.

















